David Malcom Rodman serves as Executive at Nivalis Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Malcom Rodman has executed 58 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 10, 2023 involved selling 74,625 shares valued at $982.1K.
David Malcom Rodman currently holds 51,300 shares of Nivalis Therapeutics, Inc. (NVLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Malcom Rodman has been a net seller of NVLS stock. They have purchased $0 and sold $4.6M worth of shares.
David Malcom Rodman's most recent insider trade was on Aug 10, 2023, when they sold 74,625 shares at $13.16 per share.
Get notified when new Form 4 filings are submitted
| $0.54 |
| Discretionary |
| Jan 4, 2017 | NVLS | $15.2K | Sale | 6,687 | $2.27 | Discretionary |
| Jan 3, 2017 | NVLS | $0 | Option Exercise | 18,055 | $N/A | Discretionary |
| Oct 4, 2016 | NVLS | $46.3K | Sale | 5,820 | $7.96 | Discretionary |
| Oct 3, 2016 | NVLS | $0 | Option Exercise | 18,056 | $N/A | Discretionary |
| Jul 5, 2016 | NVLS | $27.7K | Sale | 5,950 | $4.66 | Discretionary |
| Jul 1, 2016 | NVLS | $0 | Option Exercise | 18,055 | $N/A | Discretionary |